EDESA BIOTECH, INC. Accumulated Other Comprehensive Income
EDESA BIOTECH, INC. (EDSA) had Accumulated Other Comprehensive Income of -$158.54 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$158.54K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$186.09K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$171.09K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$165.77K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$158.54K 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$186.09K 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$171.09K 10-Q · filed 2026-02-13 |
| 2025-09-30 | -$165.77K 10-Q · filed 2026-08-13 |
| 2025-06-30 | -$123.08K 10-Q · filed 2025-08-08 |
| 2025-03-31 | -$287.69K 10-Q · filed 2025-05-14 |
| 2024-12-31 | -$223.96K 10-Q · filed 2025-02-14 |
| 2024-09-30 | -$242.61K 10-K · filed 2025-12-12 |
| 2024-06-30 | -$224.79K 10-Q · filed 2024-08-09 |
| 2024-03-31 | -$226.40K 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$215.22K 10-Q · filed 2024-02-09 |
| 2023-09-30 | -$214.65K 10-K · filed 2024-12-13 |
| 2023-06-30 | -$190.19K 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$230.03K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$238.67K 10-Q · filed 2023-02-10 |
| 2022-09-30 | -$213.60K 10-K · filed 2023-12-15 |
| 2022-06-30 | -$125.79K 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$160.35K 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$173.41K 10-Q · filed 2022-02-14 |
| 2021-09-30 | -$205.26K 10-K · filed 2022-12-16 |
| 2021-06-30 | -$20.13K 10-Q · filed 2021-08-13 |
| 2021-03-31 | -$194.26K 10-Q · filed 2021-05-14 |
| 2020-12-31 | -$183.78K 10-Q · filed 2021-02-16 |
| 2020-09-30 | -$287.20K 10-K · filed 2021-12-28 |
| 2020-06-30 | -$294.90K 10-Q · filed 2020-08-12 |
| 2020-03-31 | -$363.87K 10-Q · filed 2020-05-15 |
| 2019-12-31 | -$323.96K 10-Q · filed 2020-02-13 |
| 2019-09-30 | -$342.07K 10-K · filed 2020-12-07 |
| 2019-06-30 | -$329.28K 10-Q · filed 2019-08-14 |
| 2018-12-31 | -$429.97K 10-KT · filed 2019-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |